reviewNature Reviews Drug DiscoveryOct 16, 2015Closed access

Targeting key proximal drivers of type 2 inflammation in disease

Regeneron (United States) · Sanofi (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

739
total citations
FWCI
16.77
Percentile
100%
References
157
Citations per year

Authors

6

Topics & keywords

Keywords
  • Medicine
  • Asthma
  • Immunology
  • Atopic dermatitis
  • Inflammation
  • Population
  • Disease
  • Immunoglobulin E
No related works found for this paper.

Funding